In a recent episode of The Joe Rogan Experience featuring evolutionary biologist Bret Weinstein, podcast host Joe Rogan offered a nuanced perspective on the controversial weight-loss d**g Ozempic. He defended its use for individuals struggling with severe obesity while acknowledging concerns about its widespread adoption.
During the conversation, Rogan made clear distinctions about who should consider using the medication.
“If you can give someone a little boost, I don’t think there’s anything wrong with that,” Rogan stated, specifically referring to people facing extreme weight challenges. He emphasized that for someone who is “500 pounds and can’t stop eating,” appetite suppressants like Ozempic could provide crucial assistance in reaching a healthier weight.
Rogan’s position centers on the unique difficulty of food addiction compared to other dependencies. “Food is one of the most unique addictions in that it’s one that you have to moderate but you can’t quit,” he explained. “Like you can quit gambling, you can quit smoking crack, you can’t quit eating.” This perpetual exposure to the source of addiction, he argued, makes weight loss particularly challenging for those with genuine eating disorders.
However, Rogan was careful to draw boundaries around appropriate use. “For regular people, no. God damn it. Clean up your diet, go to the gym, cut the s**t,” he declared.
His support for Ozempic applies specifically to individuals facing dire health situations—those carrying hundreds of excess pounds who have struggled to break cycles of unhealthy eating through conventional means.
The discussion also touched on legitimate concerns about the medication. Weinstein raised questions about long-term safety and the problematic notion of taking any d**g indefinitely.
Rogan acknowledged these worries but maintained that for severely obese individuals, the health risks of remaining at dangerous weights might outweigh potential medication side effects. “Being 300 pounds is really freaking unhealthy,” he noted, suggesting that in such cases, Ozempic might represent a reasonable trade-off.
Rogan also addressed the importance of proper dosing and medical supervision, mentioning insights from Brigham Beller, who runs a compounding pharmacy. According to Rogan, pharmaceutical companies may have financial incentives to prescribe higher doses than necessary, whereas compounding pharmacies can tailor dosages to individual body mass and weight loss goals, potentially reducing adverse effects like muscle and bone loss.
Ultimately, Rogan’s position presents Ozempic as a potential tool rather than a universal solution. He says it’s appropriate for those facing genuine health emergencies from extreme obesity, but not a substitute for lifestyle changes in the broader population.
“That to me is the most important thing,” he said. “The most important thing is getting your body to a point where you can be mobile, you can move it, you can do stuff, you have strength.”
